Clinical Features of Parosmia Associated With COVID-19 Infection.

ABSTRACT:

Objective

To characterize the clinical features, risk factors, symptom time-course, and quality of life implications for parosmia among coronavirus disease (COVID)-related olfactory dysfunction patients.

Methods

Individuals with olfactory dysfunction associated with laboratory-confirmed or clinically suspected COVID-19 infection were recruited from otolaryngology and primary care practices over a period from August 2020 to March 2021. Participants completed olfactory dysfunction and quality of life surveys.

Results

A total of 148 (64.1%) of 231 respondents reported parosmia at some point. Parosmia developed within 1 week of any COVID-19 symptom onset in 25.4% of respondents, but more than 1 month after symptom onset in 43.4% of respondents. Parosmia was associated wit

SUBMITTER: Lerner DK 

PROVIDER: S-EPMC9015517 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature